Extended Data Fig. 1: Neutralization curves with mAbs and variant SARS-CoV-2 strains.
From: In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Anti-SARS-CoV-2 human mAbs were tested for inhibition of infection of the indicated viruses on Vero-TMPRSS2 cells using a focus reduction neutralization test. One representative experiment of two performed in duplicate is shown.
